Ronin’s Saigon testnet has migrated to Optimism as part of its Ethereum-aligned Layer 2 transition, with mainnet migration planned in the coming months. The postRonin’s Saigon testnet has migrated to Optimism as part of its Ethereum-aligned Layer 2 transition, with mainnet migration planned in the coming months. The post

Ronin Confirms Saigon Testnet Move To Optimism, Signals Upcoming Mainnet Migration

2026/02/09 15:17
2 min read
Ronin Confirms Saigon Testnet Move To Optimism, Signals Upcoming Mainnet Migration

Ronin, a blockchain platform focused on infrastructure for developer-led, player-owned digital economies, has confirmed that its Saigon test network has successfully completed a migration to Optimism, marking a major step in the network’s broader transition toward an Ethereum-aligned Layer 2 architecture. 

Developers planning to operate Saigon RPC nodes are advised to follow updated setup instructions, while regular users are not required to take any action, with games, applications, and the Ronin Wallet continuing to function as usual. The company indicated that, if the current timeline proceeds as expected, the mainnet migration will occur in the coming months.

Ronin said the production network is expected to undergo a similar migration in the coming months, in line with a previously announced Q1–Q2 target window. According to Ronin, the move is intended to improve transaction performance, provide a more balanced reward structure for developers, and enable the network to rely on Ethereum’s underlying security model. 

The Ronin Ecosystem Team is preparing a public town hall to outline the technical and operational impact of the migration. Developers planning to operate testnet nodes have been advised to update their infrastructure to support reth and op-node software and to use the latest state snapshot before restarting Saigon remote procedure call services. 

Saigon Testnet: Ronin’s Development Network For Smart Contracts, Protocol Upgrades, And Gaming-Focused Blockchain Apps

Saigon Testnet remains the official testing environment for the Ronin blockchain, allowing developers to deploy and evaluate smart contracts and decentralized applications without financial risk to the main network. 

The testnet is also used to trial protocol upgrades, including changes to consensus mechanisms such as delegated proof-of-stake, and to validate integrations with core tools and services such as the Ronin wallet, Katana, cross-chain bridges, and common token standards including ERC-20 and ERC-721.

Ronin is a blockchain network originally developed by Sky Mavis, the creators of the play-to-earn game Axie Infinity, to address scalability and cost issues on Ethereum by providing a faster, lower-fee environment specifically suited for gaming, NFTs, and related decentralized applications.

The post Ronin Confirms Saigon Testnet Move To Optimism, Signals Upcoming Mainnet Migration appeared first on Metaverse Post.

Market Opportunity
Movement Logo
Movement Price(MOVE)
$0.02131
$0.02131$0.02131
-3.79%
USD
Movement (MOVE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26